对于慢性阻塞性肺病的急性恶化,十种CPM的比较有效性:系统性审查和网络元分析
Keying Li1, Wenrui Huang1, Tuliang Liang2
1The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
Frontiers in medicine
|February 2, 2026
概括
中国专利药物 (CPM) 显示出改善慢性阻塞性肺病 (AECOPD) 急性恶化结果的潜力. 然而,证据的确定性较低,需要进一步进行高质量的研究来证实这些发现.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 综合医学是一个整体医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (AECOPD) 的急性恶化是中国的一个重要呼吸道疾病.
- 对AECOPD有效的治疗策略至关重要.
研究的目的:
- 评估中国专利药物 (CPM) 治疗AECOPD的疗效和安全性.
- 在AECOPD管理中对CPM进行随机对照试验 (RCT) 的综合证据.
主要方法:
- 进行了RCT的系统审查和元分析.
- 数据从多个数据库中提取,并使用Cochrane RoB 2.0.0评估偏差风险.
- 关键结局包括总有效率,肺功能,血气指数,炎症标志物和不良事件.
主要成果:
- 分析了84个RCT,涉及8477名参与者和10名CPM.
- 一些CPM显示,总有效率,肺功能 (FVC,FEV1) 和炎症标志物 (IL-6,IL-8,TNF-α) 的改善.
- 对于与常规疗法 (CT) 结合的CPM,没有观察到不良事件的显著增加.
结论:
- 通过改善临床结果和炎症概况,CPM可以为AECOPD患者提供好处.
- 目前的证据的确定性低至非常低,需要通过高质量的研究来验证.
- 进一步严格的研究是必要的,以证实CPM在AECOPD的治疗作用.
相关概念视频
Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K


